Literature DB >> 1698880

Transfection and gene expression in normal and malignant primary B lymphocytes.

M Buschle1, M K Brenner, I S Chen, H G Drexler, S M Gignac, C M Rooney.   

Abstract

Although many different protocols for transfection of lymphoid cell lines exist, successful DNA transfer into primary B lymphocytes has, to date, not been demonstrated. We now describe a simple method for gene transfer into highly purified normal and malignant B lymphocytes by electroporation. Using a powerful expression vector containing two copies of the cytomegalovirus (CMV) immediate early enhancer linked to the human T cell lymphotropic virus I (HTLV I) promoter, we could demonstrate transfected gene expression in both high density small 'resting' B cells and in low density 'activated' B cells. Successful transfection was detected by expression of chloramphenicol acetyl transferase and by immunofluorescence. The neoplastic cells of B cell chronic lymphocytic leukemia could also be transfected with an efficiency of 5-10%, but only after preactivation. This method of transfection will permit analysis of the contribution of individual genes and their products to normal and malignant B cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698880     DOI: 10.1016/0022-1759(90)90321-l

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression.

Authors:  A J Sinclair; M Brimmell; P J Farrell
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.

Authors:  C M Rooney; M Brimmell; M Buschle; G Allan; P J Farrell; J L Kolman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.

Authors:  A J Sinclair; I Palmero; A Holder; G Peters; P J Farrell
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Authors:  Shiri Weinstein; Itai A Toker; Rafi Emmanuel; Srinivas Ramishetti; Inbal Hazan-Halevy; Daniel Rosenblum; Meir Goldsmith; Avigdor Abraham; Ohad Benjamini; Osnat Bairey; Pia Raanani; Arnon Nagler; Judy Lieberman; Dan Peer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-23       Impact factor: 11.205

5.  Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.

Authors:  Martin M Fabani; Cei Abreu-Goodger; Donna Williams; Paul A Lyons; Adrian G Torres; Kenneth G C Smith; Anton J Enright; Michael J Gait; Elena Vigorito
Journal:  Nucleic Acids Res       Date:  2010-03-11       Impact factor: 16.971

6.  DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective.

Authors:  M J Allday; G J Inman; D H Crawford; P J Farrell
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.